Wire Stories

Analytics Insight Magazine Names �The 10 Most Innovative Intelligent Automation Solution Providers in 2020�

SAN JOSE, Calif. & HYDERABAD, India--(BUSINESS WIRE)--#ArtificialIntelligence--Analytics Insight Magazine, a brand of Stravium Intelligence has announced ‘The 10 Most Innovative…

5 years ago

China’s Mattress Maker SLEEMON Creatively Integrated the World’s Top Technologies for a Better Mattress

MILAN--(BUSINESS WIRE)--Chinese mattress brand SLEEMON released the latest antibacterial mattress products recently. This series of mattresses integrates American DuPont Intellifresh…

5 years ago

Business as Usual at Hytera�s Intelligent Manufacturing Center Amid COVID-19

Hytera’s intelligent manufacturing center in Shenzhen has enabled it to maintain production despite the disruption caused by the COVID-19 pandemic.…

5 years ago

COMPUTEX 2020 Rescheduled to September

Presenting 5G & communications, smart solutions, gaming, and startups TAIPEI--(BUSINESS WIRE)--#COMPUTEX2020--Unfortunately, the world is affected by severe infectious pneumonia (COVID-19).…

5 years ago

Cloudflare and Alibaba Cloud Collaborate on Expansion of Bandwidth Alliance

Joint customers outside mainland China can have bandwidth fees waived SAN FRANCISCO--(BUSINESS WIRE)--Cloudflare, Inc. (NYSE: NET), the security, performance, and…

5 years ago

Dynavax and Clover Biopharmaceuticals Announce Research Collaboration to Evaluate Coronavirus (COVID-19) Vaccine Candidate with CpG 1018 Adjuvant

Dynavax is providing CpG 1018, the adjuvant contained in U.S. FDA-approved HEPLISAV-B vaccine, to support the rapid development of Clover’s…

5 years ago

Renesas Introduces RX23E-A MCU Starter Kit to Jumpstart Accurate Analog Evaluation for Industrial Automation and Measurement Equipment

New RSSK Enables Analog Characteristics Evaluation at the Nanovolt Level, Accelerating Time to Market for Industrial IoT Sensors TOKYO--(BUSINESS WIRE)--#IIoT--Renesas…

5 years ago

Laekna Acquires Exclusive Global Rights to Clinical-Stage Cancer Asset

China-based biotechnology company signs third agreement with pharmaceutical company gaining exclusive global rights to develop and commercialize anti-PD-L1 Antibody Oncology…

5 years ago

Samsung Bioepis Announces FDA Approval of 420 mg Multi-dose Vial of ONTRUZANT� (trastuzumab-dttb)

●150 mg and 420 mg vial of ONTRUZANT® are now approved INCHEON, Korea--(BUSINESS WIRE)--Samsung Bioepis Co., Ltd. today announced that…

5 years ago

IASO Biotherapeutics Raises $60 Million in Series B Financing Led by GL Ventures to Advance Cell Therapies for Cancer Care

NANJING, China--(BUSINESS WIRE)--IASO Biotherapeutics (IASO BIO) today announced the completion of $60 million in series B financing led by GL…

5 years ago